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Preventing and Controlling Bleeding in Gastric Endoscopic  
Submucosal Dissection
Chan Hyuk Park and Sang Kil Lee
Division of Gastroenterology, Department of Internal Medicine, Yonsei Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, 
Korea
Although techniques and instruments for endoscopic submucosal dissection (ESD) have improved, bleeding is still the most common 
complication. Minimizing the occurrence of bleeding is important because blood can interfere with subsequent procedures. Generally, 
ESD-related bleeding can be divided into intraprocedural and postprocedural bleedings. Postprocedural bleeding can be further classi-
fied into early post-ESD bleeding which occurs within 48 hours after ESD and late post-ESD bleeding which occurs later than 48 hours 
after ESD. A basic principle for avoiding intraprocedural bleeding is to watch for vessels and coagulate them before cutting. Several 
countertraction devices have been designed to minimize intraprocedural bleeding. Methods for reducing postprocedural bleeding in-
clude administration of proton-pump inhibitors or prophylactic coagulation after ESD. Medical adhesive spray such as n-butyl-2-cyano-
acrylate is also an option for preventing postprocedural bleeding. Various endoscopic treatment modalities are used for both intraproce-
dural and postprocedural bleeding. However, hemoclipping is infrequently used during ESD because the clips interfere with subsequent 
resection. Bleeding that occurs as a result of ESD can usually be managed easily. Nonetheless, more effective ways to prevent bleeding, 
including reliable ESD techniques, must be developed.
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INTRODUCTION
Endoscopic submucosal dissection (ESD) was developed 
for en bloc resections for all tumor sizes and locations.1 ESD 
is an advanced technique with a long procedure time com-
pared to endoscopic mucosal resection (EMR).2,3 In addition, 
intraoperative bleeding is more frequent during ESD than 
during EMR.4 Although ESD techniques and instruments 
have improved, bleeding is still the most common complica-
tion.5,6 Minimizing bleeding is important because blood in-
terferes with subsequent endoscopic procedures. In this re-
view, we discuss how to avoid and control ESD-related blee-
ding.
CLASSIFICATION OF ESD-RELATED 
BLEEDINGS
ESD-related bleedings are generally divided into intrapro-
cedural and postprocedural bleedings. Postprocedural bleed-
ings are further classified into early post-ESD bleeding within 
48 hours of ESD and late post-ESD bleeding later than 48 
hours after ESD.7
Intraprocedural bleeding can develop during ESD includ-
ing during submucosal injection, incision, or dissection. Fig. 
1 shows the various types of intraprocedural bleeding. Sub-
mucosal vasculature is abundant in the stomach and precisely 
predicting the distribution of submucosal vessel is difficult. 
Therefore, intraprocedural bleeding is hard to avoid and oc-
curs in almost all ESDs. However, reported intraprocedural 
bleeding rates vary from 22.6% to 90.6%.4,8,9 This discrepancy 
in rates is due to different intraprocedural bleeding defini-
tions, which range from inconsequential bleeding that stops 
spontaneously to massive bleeding that requires transfusion 
or termination of the ESD.
Postprocedural bleeding manifests as hematemesis and/or 
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Fig. 1. Examples of intraprocedural bleeding. (A) A saline solution containing epinephrine (0.01 mg/mL) mixed with indigo carmine was in-
jected into the submucosal layer using a 21-gauge needle to lift the lesion from the muscle layer. (B) Bleeding from the injected site can be 
controlled relatively easily with strategies including spontaneous hemostasis, saline spray with diluted epinephrine, and compression with 
an endoscope tip. (C) Circumferential incision in the stomach upper body. (D) Bleeding from needle knife incision. Bleeding in the upper 
body occurs because of abundant submucosal blood vessels with large diameters. This bleeding is more serious than bleeding from injec-
tions. Bleeding from lesions comes into the endoscope cap, which is retroflexed, obscuring the vision. (E) Bleeding from insulated tipped 
knife incision. (F) Bleeding could not be identified here, and therefore (G, H) additional incisions were performed in order to see the bleed-
ing source more clearly. Coagulation of the abundant vascular networks using a knife with swift mode was performed.
A  B
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melena and a drop in hemoglobin. Postprocedural bleeding 
occurs in 1.3% to 11.9% of patients who undergo ESD (Table 
1).7,10-29 Although about 50% to 70% of bleeding is observed 
within 2 days of ESD, bleeding can develop as late as 2 weeks 
after the procedure.13,30 Late post-ESD bleeding that appears 
after patients are discharged is a concern for both endosco-
pists and patients, because urgent outpatient treatment is dif-
ficult.
RISK FACTORS FOR ESD-RELATED 
BLEEDING
To determine how to minimize ESD-related bleeding, stud-
ies have evaluated risk factors for bleeding after ESD. Intra-
procedural bleeding develops more commonly with lesions in 
the upper third of the stomach3,8 because of abundant distri-
bution of vessels in the submucosa.31 Technical difficulty co-
uld be another reason for frequent bleeding. In contrast to in-
traprocedural bleeding, postprocedural bleeding is observed 
more frequently at lesions in the middle or lower third of the 
stomach.3,32-34 Large specimen size is a well-known risk factor 
for postprocedural bleeding, with studies finding that post-
procedural bleeding increases for lesions that are widely re-
sected (≥40 mm).23,32,35 The possibility that antiplatelet agents 
are risk factors for intraprocedural or postprocedural bleed-
ing is controversial. The 2009 American Society for Gastroin-
testinal Endoscopy guidelines recommended continued treat-
ment with aspirin.36 However, the European Society of Gas-
trointestinal Endoscopy guidelines recommend discontinua-
tion of aspirin for 5 days in patients with low thrombotic 
risk.37 The guidelines were based on observational studies, ex-
pert opinions, and best clinical practices, and rarely supported 
by prospective randomized studies. To draw definite conclu-
sions, well-designed prospective studies are needed. A recent 
large, retrospective study showed that antithrombotic drugs 
are risk factors for late post-ESD bleeding.35 Since large artifi-
cial ulcers are related to a high postprocedural bleeding rate, 
antiplatelet agents that interfere with artificial ulcer healing 
could be a risk factor for postprocedural bleeding. Therefore, 
careful administration of antiplatelet agents could be needed, 
even without evidence of bleeding at the time of drug reinitia-
tion.
Table 1. Incidence of Postprocedural Bleeding
Reference Year Design Total cases
Delayed bleeding, 
no. (%)
En bloc resection, 
no. (%)
Others
Białek et al.10 2013 R 103       2 (1.9)         93 (90.3)
Nonaka et al.11 2013 R 139       2 (1.4)      131 (94) Remnant stomach, postgastrectomy
Kosaka et al.12 2013 R 438    19 (4.3)      428 (97.7)
Ryu et al.13 2013 P 155    21 (11.9)      135 (87) Early+Late
Lim et al.7 2013 R 1,461    19 (1.3) 1,371 (93.8)
Ahn et al.14 2013 R 51       2 (3.9)           49 (96.1) Transnasal endoscopy
Toyonaga et al.15 2013 R 1,136    41 (3.6) 1,128 (99.3)
Kim et al.16 2012 R 440       9 (2.0) NA Prophylactic hemostasis at second- 
  look endoscopy: 1 case
Lee et al.17 2012 R 31       1 (3.2)          30 (97) Diagnostic ESD
Nakamura et al.18 2012 R 544    38 (7.0)      519 (95.4)
Mukai et al.19 2012 R 161       6 (3.7) NA After 48 hours
Tokioka et al.20 2012 R 515    26 (5.0)      485 (94.2)
Tomita et al.21 2012 P 156    10 (6.4) NA
Schumacher et al.22 2012 P 30       2 (6.67)         27 (90.0) Water jet-assisted knife
Lim et al.23 2012 R 1,591    94 (5.91) NA
Cho et al.24 2012 R 514    21 (4.09) NA
Toyokawa et al.25 2012 R 1,123    56 (4.99) 1,051 (93.6)
Goto et al.26 2012 R 1,814 100 (5.50) NA Within 24 hours: 62
Abe et al.27 2012 R 470    15 (3.19)      366 (77.9) Advanced age (>80)
Higashiyama et al.28 2011 R 924    28 (3.03) NA
Ahn et al.29 2011 R 1,370    91 (6.64) 1,180 (86.1)
R, retrospective study; P, prospective study; NA, not analyzed; ESD, endoscopic submucosal dissection.
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PREVENTING ESD-RELATED BLEEDING
A basic principle for avoiding intraprocedural bleeding is to 
watch for vessels, and coagulate them before cutting (Fig. 2). 
In addition, understanding the anatomical characteristics of a 
particular area of the stomach is essential for a successful and 
safe ESD. The antrum has little fibrotic tissue and low density 
vasculature in the submucosal layer.38 The lesser curvature of 
the stomach body has little fibrotic tissue, similar to the an-
trum; however, it has large-diameter, perforating vessels. In 
contrast to the lesser curvature of the stomach body, the ante-
rior and posterior wall sides have more perforating branches 
and fibrotic submucosa, which generally makes incision and 
dissection more difficult.
Endoscopic ultrasonography (EUS) was used to evaluate 
submucosal vascular structure to predict intraprocedural bl-
eeding. A retrospective study by Kikuchi et al.39 showed that 
the frequency of clip use was higher in lesions rich in vascular 
structure compared to lesions without rich vascular structure. 
Their subsequent prospective study revealed that EUS pre-
dicted procedure time, muscle injury incidence, and frequen-
cy of clip use. However, intraprocedural bleeding could not be 
predicted by preoperative EUS findings.40 Various counter-
traction devices have been developed to minimize intraproce-
dural bleeding.41 Methods using these devices include trans-
nasal endoscope-assisted ESD, external grasping-type forceps, 
Fig. 2. Watch for vessels, and coagulate them before cutting to prevent intraprocedural bleeding. Understanding stomach anatomical char-
acteristics such as large-diameter perforating vessels in the lesser body curvature is important. Submucosal dissection in this area should 
be cautious compared to the antrum. (A-C) During submucosal dissection, one large vessel was identified, and dissection was stopped. (D-
F) Thermocoagulation hemostasis using hemostatic forceps was performed.
A  B
C D
E F
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yo-yo technique, and clip-band technique. All countertrac-
tion devices expose the submucosa to the endoscopist’s visual 
field for easier and safer ESD. Some devices, however, require 
an additional assistant.
The best way to reduce postprocedural bleeding is adminis-
tration of a proton-pump inhibitor (PPI) (Table 2).21,42-45 In 
several studies, PPIs were superior to histamine-2-receptor 
antagonists at preventing postprocedural bleeding;46 however, 
preoperative administration of PPIs might not offer addition-
al benefit.47 In addition, the optimal duration of PPI adminis-
tration among patients who undergo ESD is unclear. A pro-
spective study from Japan concluded that administration of 
PPIs for 2 weeks for ESD-induced ulcers might be sufficient 
to aid healing without increasing the risk of adverse effects.48 
Another study showed that the optimal duration of PPI treat-
ment varies based on the ESD-induced ulcer size; patients 
with an ESD-induced ulcer larger than 40 mm should be 
treated with an 8-week course of PPIs.43 Another well-known 
method for preventing postprocedural bleeding is prophylac-
tic coagulation of visible vessels in the resection area.33 Many 
endoscopists agree that prophylactic coagulation of nonbleed-
ing visible vessels is necessary. However, aggressive, routine 
coagulation of all visible vessels could risk perforation, al-
though this possibility has not been confirmed in a trial. 
Some investigators, therefore, have developed methods to try 
to identify vessels that have a low risk of bleeding. One meth-
od uses infrared imaging.49 Yoshida et al.49 classified non-
bleeding visible vessels a blue or gray points using this system 
and water-jet pressure was applied to an artificial ulcer base to 
induce iatrogenic bleeding. Vessels with blood flow were dark 
gray from infrared absorption by hemoglobin; coagulated 
vessels were blue. Iatrogenic bleeding occurred only at gray 
and not blue points. Doppler ultrasonography (US) has also 
been used to distinguish low-risk vessels for bleeding. Uedo et 
al.50 performed prophylactic coagulation using Doppler US 
signals in 10 patients who underwent ESD. No postprocedur-
al bleeding was observed. Although these were pilot studies 
and the methods have not been generalized, these types of ef-
forts will improve ESD techniques and safety. Another meth-
od suggested to reduce postprocedural bleeding is second-
look endoscopy after ESD, which many endoscopists per-
form.26,30 However, evidence that second-look endoscopy re-
duces postprocedural bleeding is lacking.13,30 Recently, a new 
method for preventing postprocedural bleeding using medi-
cal adhesive such as n-butyl-2-cyanoacrylate was reported by 
a Chinese prospective study. The study revealed that medical 
adhesive spray is effective in preventing postprocedural bleed-
ing (medical adhesive group vs. control group, 0% vs. 4.88%; 
p=0.035).51 Since medical adhesives are usually used to treat 
gastric varices, the results were unexpected. Medical adhesive 
spray could be an option for preventing postprocedural bleed-
ing.
Table 2. Drugs for Treating Artificial Ulcer
Reference Year Cases Drug Duration
Follow-up, 
wk
Ulcer size, mm2 Healing rate, %
Tomita et al.21 2012 79 Famotidine 20 mg, twice a day 8 weeks 6 1,176.4±1,230.5 97.9
77 Omeprazole 20 mg, twice a day 
  (3 day) → once a day
4-8 weeks 1,367.6±1,167.9 98.4
Shin et al.42 2012 138 Pantoprazole 40 mg, once a day 28 days 4 1,257.3±1,062.7 89.9
140 Pantoprazole 40 mg, once a 
  day+rebamipide 100 mg, thrice a day
28 days 1,297.4±1,470.3 94.9
Lee et al.43, a) 2012 30 Proton pump inhibitor 1 week         39.03±13.78 mm 50.0
34 4 weeks         39.28±15.88 mm 61.8
128 8 weeks         49.33±16.61 mm 80.5
Kobayashi et al.44, b) 2012 85 Rabeprazole 20 mg or lansoprazole  
  30 mg
8 weeks 4-6 NA 66 (marginal healing)
72 (basal healing)
85 Rabeprazole 20 mg or lansoprazole  
  30 mg+rebamipide 300 mg
8 weeks NA 69 (marginal healing)
80 (basal healing)
Kim et al.45, c) 2010 30 Revaprazan 200 mg 8 weeks         31.9±13.6 mm 97.0
30 Rabeprazole 20 mg 8 weeks         27.7±9.4 mm               100.0
Values are presented as mean±SD.
NA, not analyzed.
a)Retrospective study; b)Lansoprazole 30 mg given to all patients for an initial 2 days before study medication was started; c)Matched case-con-
trol study. Intravenous pantoprazole 80 mg given 2 hours before endoscopic submucosal dissection to all patients followed by 8 mg/hr intra-
venous pantoprazole was given continuously.
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CONTROLLING ESD-RELATED  
BLEEDING
For cases of intraprocedural bleeding, the hemostatic met-
hod should be chosen according to the appearance and the 
severity of the bleeding. Minimal bleeding can be controlled 
with epinephrine spray, compression by the tip of an endo-
scope, or subtle coagulation by electrosurgical knives such as 
an insulated-tipped knife. Bleeding can stop spontaneously, 
so waiting briefly is an option for controlling intraprocedural 
bleeding. Severe bleeding that cannot be easily controlled sh-
ould be treated with a hemostasis device. Epinephrine mixed 
into a solution that acts as a submucosal cushion is useful for 
both peptic and ESD-induced ulcers.52 The most common 
method for controlling severe bleeding is thermocoagulation 
hemostasis using hemostatic forceps.53 These forceps have 
been developed especially for hemostasis and have a narrow 
opening angle, a small cup, and a blunt edge to ensure effi-
cient electrocoagulation.53,54 If the exact bleeder cannot be id-
entified, broad coagulation of the lesion or trimming the sub-
mucosal layer to expose the bleeder should be considered. 
However, excessive coagulation increases the resistance to ele-
ctrical cutting, interfering with subsequent procedures. He-
moclipping is an alternative for hemostasis of intraprocedural 
bleeding; however, it is used less often during ESD because 
endoscopic clips interfere with subsequent resection proce-
dures.5
To control post-ESD bleeding, various endoscopic treat-
ment modalities can be used individually or in combination. 
Early in the healing period of artificial ulcer, the ulcer base is 
still soft with little granulation tissue, so endoscopic clips or 
electrocautery using hemostatic forceps can be applied to 
control the bleeding.5 Late in the healing period, the artificial 
ulcer base hardens with granulation tissue, so the injection 
method is preferable.5 Although almost all bleeding events 
can be controlled endoscopically, interventional radiologic 
methods for vascular embolization or surgery are also hemo-
stasis options and should be considered when endoscopic ma-
nagement fails or disseminated intravascular coagulation is 
developed.
CONCLUSIONS
Although bleeding often occurs as a result of ESD, it can al-
most always be easily managed. However, more effective ways 
to prevent ESD-related bleeding, including reliable ESD tech-
niques, must be developed.
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